Breast Cancer Clinical Trial
Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer
Summary
The standard treatment for breast cancer when cancer cells were found near or within the margins of the tissue that is removed during breast surgery, is radiation of the entire chest wall. This may be considered overtreatment since the only reason for doing so is that cancer cells were near or in the margins of the breast tissue that was removed. In this study, the amount of radiation treatment will be limited to the area where the remaining cancer cells were found after surgery.
The purpose of this study is to find out if partial chest wall radiation therapy is as good as whole chest wall radiation therapy in reducing the risk of breast cancer cancer coming back.
Eligibility Criteria
Inclusion Criteria:
DCIS or stage T1 or T2 invasive breast cancer, lymph node negative
Must have undergone mastectomy
Presence of cancer cells on or close to surgical margins
Negative pregnancy test for women
Must receive radiation at Stony Brook University Hospital
Exclusion Criteria
- Received prior radiation to are to be irradiated
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.